Back
Nuvation Bio, Inc. Vs. Spyre Therapeutics, Inc. Industry Stock Comparison
Sell
40
NUVB
Nuvation Bio, Inc.
Last Price:
$4.42
Seasonality Move:
8.74%
Buy
63
SYRE
Spyre Therapeutics, Inc.
Last Price:
$47.58
Seasonality Move:
-1.09%
Sell
40
Nuvation Bio, Inc. (NUVB)
is a Sell
Is Nuvation Bio, Inc. a Buy, Sell or Hold?
-
The current Nuvation Bio, Inc. [NUVB] share price is $4.41. The Score for NUVB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
NUVB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Spyre Therapeutics, Inc. (SYRE)
is a Buy
Is Spyre Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Spyre Therapeutics, Inc. [SYRE] share price is $47.58. The Score for SYRE is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
SYRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NUVB Stock Price Chart
What is Nuvation Bio, Inc.'s stock price today?
-
The Nuvation Bio, Inc. share price today is $4.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUVB is experiencing selling pressure, which indicates risk of future bearish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics, Inc.'s stock price today?
-
The Spyre Therapeutics, Inc. share price today is $47.58The current trend is moderately bullish and SYRE is experiencing slight buying pressure.
NUVB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.14 | Buy |
| Relative Strength Index (14 RSI): | 43.68 | Sell |
| Chaikin Money Flow: | -2410730 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.11 - 4.97) | Sell |
| Bollinger Bands (100): | (4.62 - 7.98) | Sell |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.39 | Buy |
| Relative Strength Index (14 RSI): | 60.73 | Buy |
| Chaikin Money Flow: | 101552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.42 - 46.32) | Buy |
| Bollinger Bands (100): | (28.36 - 41.52) | Buy |
NUVB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.32 | Buy |
| 20-day SMA: | 4.4 | Buy |
| 50-day SMA: | 5.09 | Sell |
| 200-day SMA: | 4.68 | Sell |
| 8-day EMA: | 4.13 | Buy |
| 20-day EMA: | 3.02 | Buy |
| 50-day EMA: | 1.64 | Buy |
| 200-day EMA: | 0.49 | Buy |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.88 | Buy |
| 20-day SMA: | 43.85 | Buy |
| 50-day SMA: | 39.64 | Buy |
| 200-day SMA: | 26.25 | Buy |
| 8-day EMA: | 46.92 | Buy |
| 20-day EMA: | 44.54 | Buy |
| 50-day EMA: | 40.51 | Buy |
| 200-day EMA: | 30.19 | Buy |
Nuvation Bio, Inc. Earnings Growth & NUVB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.10 per share.
Spyre Therapeutics, Inc. Earnings Growth & SYRE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.51 per share, a decrease this year of $0.72 per share, and a decrease next year of $0.16 per share.
Nuvation Bio, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||